Skip to content
Biodatica
Start free

Fundación GECP

Ferrol, A Coruña

Oncologyliquid biopsyPhase III
Compare Sign in to watch

What changed

Phase III trial registered: New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy

2mo agoTrial registeredMay 5, 2026Source filing (opens the source filing in a new tab)

Momentum

84no change

Momentum 84 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase III

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

301 pre-ticker oncology companies at Phase III

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    Study registered

    Oct 3, 2024

    Non-small Cell Lung Cancer Stage III, PDL1 Gene Mutation · RECRUITING · sponsor: Fundación GECP · Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients

    ClinicalTrials.gov · NCT06634199 (opens the source filing in a new tab)

  2. Trial

    PHASE2 registered

    May 12, 2023

    NSCLC, Pancoast Tumor · ACTIVE_NOT_RECRUITING · sponsor: Fundación GECP · DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors

    ClinicalTrials.gov · NCT05684276 (opens the source filing in a new tab)

  3. Trial

    PHASE3 registered

    Jan 13, 2021

    Non-Small Cell Lung Cancer, Adjuvant Chemotherapy · ACTIVE_NOT_RECRUITING · sponsor: Fundación GECP · New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy

    ClinicalTrials.gov · NCT04564157 (opens the source filing in a new tab)

  4. Trial

    PHASE2 registered

    Dec 2, 2020

    Non Small Cell Lung Cancer, EGFR Gene Mutation · TERMINATED · sponsor: Fundación GECP · Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients

    ClinicalTrials.gov · NCT04512430 (opens the source filing in a new tab)

  5. Trial

    PHASE2 registered

    May 4, 2020

    Lung Cancer, NSCLC, NSCLC Stage IIIB, NSCLC Stage IV · ACTIVE_NOT_RECRUITING · sponsor: Fundación GECP · Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients

    ClinicalTrials.gov · NCT04223596 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources